Contact the referring organization directly to learn more about this start-up.

Contact Us
Logo EdiVite

Details

Status

Incorporated

Legal form

Year of establishment

VAT number

Region

TRL

5

Looking for

Investment funds

Accreditation

Innovative start-up

Revenue

Employees

Website

LinkedIn page

Certifications

Scientific publications

Keywords

Gene Editing, Viticulture, CRISPR/Cas9

Team

Loginto view data

Download the project presentation

Loginto download PDF

EdiVite

Genome Editing in grapevine

Sustainability - Rigenerative Agricolture & Molecular Farming

Description

EdiVite aims to address the challenges of modern viticulture by developing grapevine genotypes with improved characteristics, for the advancement of sustainable and economically viable vineyard management. The company's objective is to develop and apply innovative methods in grapevines compared to conventional breeding, and to produce plant prototypes with enhanced features such as disease resistance, adaptation to climate change and quality improvement, through the use of DNA-free genome editing using the CRISPR/Cas9 system.

Established start-up

Funding stage

Seed

Seeking or have received funding with equity transfers (BAs, incubators, accelerators). Funding range: € 50,001 - 250,000

Killer application

Development of genetically improved innovative plant prototypes for specific traits of interest using cutting-edge technologies.

Advantages

EdiVite has the commercial advantage of being currently the first company in the world to have successfully implemented editing technology on grapevines for the improvement of biotechnologically relevant traits without the insertion of foreign DNA. The enhanced plant prototypes ensure:

  • reduction in the use of high environmental impact phytosanitary products;;
  • preservation of the original genetic makeup and valuable qualitative characteristics;
  • production of a "clean" product, highly sought after by consumers.

Competitive scenario

Nowadays, genetically improved grapevine clones produced using genome editing DNA-free technology are not available on the market. Potential competitors include research centers capable of developing the technology, but currently focused on varieties of limited commercial relevance, at least for Europe.

Enabling technologies

  • Production of embryogenic calli from grapevine plants;
  • Isolation of grapevine protoplasts and regeneration of the whole plant;
  • Application of DNA-free genome editing on grapevine protoplasts;
  • Functional characterization of edited plants.

Revenue model

  • Sale of genetically improved grapevine prototypes;
  • Services providing.

Target customers

Private agreements with Italian and international plant nursery and winemaking companies.

Traction

R&D Collaborations:

  • University of Padua;
  • University of Naples;
  • University of Catania;
  • E&J Gallo Winery (California - USA);
  • Imperal College (London - UK).
patents-cta

Register to gain full access to this and other start-ups on our platform.

Register